| abstract |
The subject of the present invention is to provide an excellent lysosomal disease treatment agent. According to the present invention, a lysosomal disease treatment agent can be provided, which comprises a cell structure body comprising a plurality of biocompatible polymer blocks and a plurality of cells of at least one kind, and the plurality of cells At least one of the above polymer blocks is arranged in the gap. |